Note: CSS is no longer pursuing Reglan claims. This post is for educational purposes only.
Over two million Americans use products containing Reglan. This popular drug, also sold in the generic form of metoclopramide, is commonly used in treating patients suffering from gastrointestinal problems. The Food and Drug Administration and other medical sources have linked Reglan to tardive dyskinesia, a central nervous system disorder that causes involuntary, repetitive movements of the body that may become permanent. These repetitive movements can become a permanent side effect from taking Reglan even after the drug is stopped. The effects of taking Reglan can be devastating, causing severe mental, emotional, physical, and social affliction.
On February 26, 2009, the FDA required a black box warning to be placed on Reglan’s drug labels to make both patients and doctors aware of the increased risk of developing tardive dyskinesia from prolonged Reglan use. The black box is the highest warning the FDA can require for a drug and is only mandated in the most serious of cases. You may benefit from speaking with a dangerous drug attorney if you have developed a nervous system disorder after taking this drug. Our Reglan tardive dyskinesia lawyers could offer support throughout your legal case.
What is Reglan?
Reglan is typically used to treat gastroesophageal reflux disease (GERD), vomiting and nausea, heartburn, reflux, and gastroparesis. The FDA approved Reglan for only short-term use in adults of 12 weeks or less. When Reglan is used for longer than a 12-week consecutive period or in higher doses, the likelihood of developing tardive dyskinesia increases dramatically. Many doctors were unaware of these effects and FDA’s guidelines became increasingly overlooked and understated. Even with the inadequate warnings, many prescriptions continue to be written by doctors for intervals beyond the recommended 12-week period. Those who have taken Reglan should get in touch with a lawyer if they believe they may have developed tardive dyskinesia.
Symptoms of Tardive Dyskinesia
- Lip smacking
- Neck pulls
- Blinking and rapid eye movement
- Tongue protrusion
- Involuntary facial gestures
- Involuntary and impaired finger movements
- Difficulty breathing, swallowing, talking, and walking
Currently there is no known cure for Reglan-induced tardive dyskinesia, and the treatments to manage tardive dyskinesia are still in the infant stages of widespread use. Because of the severity of this condition, it is crucial to speak with a lawyer familiar with Reglan lawsuits.
With the devastating impact Reglan has on some patients, there have been a number of Reglan lawsuits filed. Over 600 reglan lawsuits have been filed to date. Below is a chart of the mostly commonly seen defendants and the national drug code that corresponds with their reglan/metoclopramide products.
Defendant Manufacturers: National Drug CODE (NDC):
|Major Pharm, Inc.||00904|
|Pharmaceutical Assoc Inc. Div. Beach Prod.||00121|
|Raubaxy Ph. Inc||63304|
|Wyeth (Richmond Div)||00031|
|Morton Pharmaceutical Company Inc.||53489|
|United Research Laboratories Inc.||00677|
|Anip Acquisition Co.||62559|
|Apothecon (terminated NDC 7/01/07)||62269|
|MedPoint (distributor for Watson)||59122-2910|
|Duramed sub Barr||51285|
Many of these drug manufacturers have been named in lawsuits filed by Childers, Schlueter & Smith, LLC regarding the dangers of Reglan.
Other Tardive Dyskinesia Resources
- The Bachmann-Strauss Dystonia & Parkinson Foundation, Inc.
- Care4Dystonia, Inc.
- Dystonia Spasmodic Torticollis
- The Movement Disorder Society
- We MOVE